These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 17628158)

  • 1. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone.
    Choi SW; Kim JH
    J Control Release; 2007 Sep; 122(1):24-30. PubMed ID: 17628158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation.
    Rawat P; Manglani K; Gupta S; Kalam A; Vohora D; Ahmad FJ; Talegaonkar S
    Pharm Res; 2015 Oct; 32(10):3149-58. PubMed ID: 25840949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
    Cong Y; Quan C; Liu M; Liu J; Huang G; Tong G; Yin Y; Zhang C; Jiang Q
    J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
    McCarron PA; Marouf WM; Donnelly RF; Scott C
    J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate.
    Cenni E; Granchi D; Avnet S; Fotia C; Salerno M; Micieli D; Sarpietro MG; Pignatello R; Castelli F; Baldini N
    Biomaterials; 2008 Apr; 29(10):1400-11. PubMed ID: 18191195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co-glycolide) nanoparticles for versatile surface modification.
    Weiss B; Schneider M; Muys L; Taetz S; Neumann D; Schaefer UF; Lehr CM
    Bioconjug Chem; 2007; 18(4):1087-94. PubMed ID: 17590034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
    Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M
    Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composites of poly(lactide-co-glycolide) and the surface modified carbonated hydroxyapatite nanoparticles.
    Hong Z; Zhang P; Liu A; Chen L; Chen X; Jing X
    J Biomed Mater Res A; 2007 Jun; 81(3):515-22. PubMed ID: 17133447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEG-PLA block copolymer as potential drug carrier: preparation and characterization.
    Ben-Shabat S; Kumar N; Domb AJ
    Macromol Biosci; 2006 Dec; 6(12):1019-25. PubMed ID: 17128420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(γ-benzyl-L-glutamate)-PEG-alendronate multivalent nanoparticles for bone targeting.
    de Miguel L; Noiray M; Surpateanu G; Iorga BI; Ponchel G
    Int J Pharm; 2014 Jan; 460(1-2):73-82. PubMed ID: 24211357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adsorption of poly(ethylene glycol)-modified ribonuclease A to a poly(lactide-co-glycolide) surface.
    Daly SM; Przybycien TM; Tilton RD
    Biotechnol Bioeng; 2005 Jun; 90(7):856-68. PubMed ID: 15841471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
    Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
    Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms.
    Santander-Ortega MJ; Jódar-Reyes AB; Csaba N; Bastos-González D; Ortega-Vinuesa JL
    J Colloid Interface Sci; 2006 Oct; 302(2):522-9. PubMed ID: 16887138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
    J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin.
    Lee H; Ahn CH; Park TG
    Macromol Biosci; 2009 Apr; 9(4):336-42. PubMed ID: 19006195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate.
    Pignatello R; Cenni E; Micieli D; Fotia C; Salerno M; Granchi D; Avnet S; Sarpietro MG; Castelli F; Baldini N
    Nanomedicine (Lond); 2009 Feb; 4(2):161-75. PubMed ID: 19193183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.